512600 (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 10,20,000 new equity shares of Astal Laboratories Limited issued at Rs. 40/- on preferential basis via conversion of warrants, … | |||||||||||||||
BSE lists 10,20,000 new equity shares of Astal Laboratories Limited issued at Rs. 40/- on preferential basis via conversion of warrants, effective May 19, 2026.
| |||||||||||||||
BSE's Surveillance department sought clarifications from 15 companies regarding significant price/volume movements. Replies received from 9 … | |||||||||||||||
BSE's Surveillance department sought clarifications from 15 companies regarding significant price/volume movements. Replies received from 9 companies; 6 companies' responses are still awaited.
| |||||||||||||||
BSE revises price bands for 26 equity scrips effective May 11, 2026, with bands ranging from 1% to 20%, as part of routine surveillance … | |||||||||||||||
BSE revises price bands for 26 equity scrips effective May 11, 2026, with bands ranging from 1% to 20%, as part of routine surveillance measures.
| |||||||||||||||